| [1] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
| [2] |
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49.
|
| [3] |
Gilles H, Garbutt T, Landrum J. Hepatocellular carcinoma[J]. Crit Care Nurs Clin North Am, 2022, 34(3): 289-301.
|
| [4] |
曹洪欣. 保持和发扬中医理论与实践的先进性的研究[J]. 中华中医药杂志, 2007(1): 3-5.
|
| [5] |
Odagi I, Kato T, Imazu H, et al. Examination of normal intestine using confocal endomicroscopy[J]. J Gastroenterol Hepatol, 2007, 22(5): 658-662.
|
| [6] |
Sugino T, Yamaguchi T, Hoshi N, et al. Sinusoidal tumor angiogenesis is a key component in hepatocellular carcinoma metastasis[J]. Clin Exp Metastasis, 2008, 25(7): 835-841.
|
| [7] |
ura G, et al. Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers[J]. BMC Med, 2004, 2: 9.
|
| [8] |
Fang JH, Zhou HC, Zhang C, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial- mesenchymal transition-independent manner[J]. Hepatology, 2015, 62(2): 452-465.
|
| [9] |
Zhang P, Ono A, Fujii Y, et al. The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma[J]. Int J Cancer, 2022, 151(12): 2278-2290.
|
| [10] |
Guo B, Cai G, Zhu J, et al. Vessels encapsulating tumor clusters is associated with impaired efficacy of adjuvant immunotherapy in resected hepatocellular carcinoma[J]. J Adv Res, 2025, S2091- 1232(25)950-6.
|
| [11] |
Zhu Y, Wang M, Cao J, et al. Vessels encapsulating tumor clusters in hepatocellular carcinoma: a distinct metastatic pathway with diagnostic and therapeutic significance[J]. J Transl Med, 2026, 24(1): 185.
|
| [12] |
Akiba J, Nakayama M, Sadashima E, et al. Prognostic impact of vessels encapsulating tumor clusters and macrotrabecular patterns in hepatocellular carcinoma[J]. Pathol Res Pract, 2022, 238: 154084.
|
| [13] |
Ding T, Xu J, Zhang Y, et al. Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection[J]. Cancer, 2011, 117(21): 4878-4889.
|
| [14] |
Liu K, Dennis C, Prince DS, et al. Vessels that encapsulate tumour clusters vascular pattern in hepatocellular carcinoma[J]. JHEP Rep, 2023, 5(8): 100792.
|
| [15] |
Yu Y, Fan Y, Wang X, et al. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters(VETC) and patient prognosis in hepatocellular carcinoma[J]. Eur Radio, 2022, 32(2): 959-970.
|
| [16] |
Chen ZY, Guo ZX, Lu LH, et al. The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma[J]. Cancer Med, 2021, 10(16): 5466-5474.
|
| [17] |
Chu T, Zhao C, Zhang J, et al. Application of a convolutional neural network for multitask learning to simultaneously predict microvascular invasion and vessels that encapsulate tumor clusters in hepatocellular carcinoma[J]. Ann Surg Oncol, 2022, 29(11): 6774-6783.
|
| [18] |
Yu Y, Liang X, Hou G, et al. Spectral computed tomography parameters for predicting vessels encapsulating tumor clusters (VETC) pattern in hepatocellular carcinoma: a pilot study[J]. Quant Imaging Med Surg, 2025, 15(4): 3285-3297.
|
| [19] |
Renne SL, Woo HY, Allegra S, et al. Vessels encapsulating tumor clusters(VETC) is a powerful predictor of aggressive hepatocellular carcinoma[J]. Hepatology, 2020, 71(1): 183-195.
|
| [20] |
Sheng X, Ji Y, Ren GP, et al. A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC[J]. Hepatol Int, 2020, 14(6): 1034-1047.
|
| [21] |
丛文铭, 步宏, 陈杰, 等. 原发性肝癌规范化病理诊断指南(2015年版)[J]. 解放军医学杂志, 2015, 40(11): 865-872.
|
| [22] |
Xu W, Huang B, Zhang R, et al. Diagnostic and prognostic ability of contrast-enhanced unltrasound and biomarkers in hepatocellular carcinoma subtypes[J]. Ultrasound Med Biol, 2024, 50(4): 617-626.
|
| [23] |
Xu W, Zhang H, Zhang R, et al. Deep learning model based on contrast-enhanced ultrasound for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma[J]. Eur Radio, 2025, 35(2): 989-1000.
|
| [24] |
Feng Z, Li H, Zhao H, et al. Preoperative CT for characterization of aggressive macrotrabecular-massive subtype and vessels that encapsulate tumor clusters pattern in hepatocellular carcinoma[J]. Radiology, 2021, 300(1): 219-229.
|
| [25] |
Ding Q, Deng X, Huang J, et al. Application value of enhanced CT imaging features in predicting vessels encapsulating tumor clusters(VETC) positivity in hepatocellular carcinoma[J]. Curr Med Imaging, 2025, 21: e15734056361565.
|
| [26] |
Liu Z, Mao Y, Liu L, et al. Preoperative CT features for characterization of vessels that encapsulate tumor clusters in hepatocellular carcinoma[J]. Eur J Radiol, 2024, 179: 111681.
|
| [27] |
Wei Y, Huang S, Huang L, et al. CT-based radiomics features combined with AFP for predicting vessels encapsulating tumor clusters and prognosis of hepatocellular carcinoma[J]. J Hepatocell Carcinoma, 2025, 12: 2069-2081.
|
| [28] |
Li C, Wen Y, Xie J, et al. Preoperative prediction of VETC in hepatocellular carcinoma using non-gaussian diffusion-weighted imaging at high b values: a pilot study[J]. Front Oncol, 2023, 13: 1167209.
|
| [29] |
Zhang J, Liu M, Qu Q, et al. Radiomics analysis of gadoxetic acid-enhanced MRI for evaluating vessels encapsulating tumour clusters in hepatocellular carcinoma[J]. Front Oncol, 2024, 14: 1422119.
|
| [30] |
Che F, Gao F, Li Q, et al. Fractal analysis based on Gd-EOB-DTPA-enhanced MRI for prediction of vessels that encapsulate tumor clusters in patients with hepatocellular carcinoma[J]. Int J Surg(lond Engl), 2025, 111(7): 4389-4399.
|
| [31] |
Pan JH, Huang HZ, Zhang SY, et al. Intraindividual comparison of CT and MRI for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma[J]. Eur Radio, 2025, 35(1): 61-72.
|
| [32] |
Chen FM, Du M, Qi X, et al. Nomogram estimating vessels encapsulating tumor clusters in hepatocellular carcinoma from preoperative gadoxetate disodium-enhanced MRI[J]. J Magn Reson Imaging, 2023, 57(6): 1893-1905.
|
| [33] |
Dong X, Yang J, Zhang B, et al. Deep learning radiomics model of dynamic contrast-enhanced MRI for evaluating vessels encapsulating tumor clusters and prognosis in hepatocellular carcinoma[J]. J Magn Reson Imaging, 2024, 59(1): 108-119.
|
| [34] |
Wang J, Cao L, Du H, et al. MRI-based habitat radiomics and deep learning for predicting vessels encapsulating tumor clusters and survival in hepatocellular carcinoma[J]. Insights into Imaging, 2025, 16(1): 284.
|
| [35] |
Granito A, Muratori L, Lalanne C, et al. Hepatocellular carcinoma in viral and autoimmune liver diseases: role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment[J]. World J Gastroenterol, 2021, 27(22): 2994-3009.
|
| [36] |
杨建荣, 钟敬涛, 刘天奇, 等. 术前超声造影和术中快速冰冻病理切片诊断VETC癌巢型肝细胞癌的价值及患者手术方式选择研究[J]. 中国临床新医学, 2021, 14(3): 262-266.
|
| [37] |
Toshida K, Itoh S, Toshima T, et al. Clinical significance of mechanistic target of rapamycin expression in vessels that encapsulate tumor cluster-positive hepatocellular carcinoma patients who have undergone living donor liver transplantation[J]. Ann Gastroenterol Surg, 2023, 8(1): 163-171.
|
| [38] |
Lyu N, Kong Y, Mu L, et al. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1): 60-69.
|
| [39] |
Wang JH, Li XS, Tang HS, et al. Vessels that encapsulate tumor clusters(VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2023, 149(8): 4163-4172.
|
| [40] |
He X, Liu Y, Dai T, et al. Pathological study of the tumor microenvironment after neoadjuvant therapy in hepatocellular carcinoma: difference of TACE combined with antiangiogenics and immunotherapy[J]. Hepatol Commun, 2025, 9(9): e0787.
|
| [41] |
Fang JH, Xu L, Shang LR, et al. Vessels that encapsulate tumor clusters(VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma[J]. Hepatology, 2019, 70(3): 824-839.
|